Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma

J Clin Oncol. 2021 Feb 10;39(5):467-475. doi: 10.1200/JCO.20.01751. Epub 2021 Jan 12.

Authors

Alvaro J Alencar¹, Craig H Moskowitz¹

Affiliation

¹ Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL.

PMID: 33434059
DOI: 10.1200/JCO.20.01751

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carmustine / administration & dosage
Clinical Trials, Phase III as Topic
Cyclophosphamide / administration & dosage
Cytarabine / administration & dosage
Etoposide / administration & dosage
Humans
Immunotherapy, Adoptive / methods
Lymphoma, Large B-Cell, Diffuse / therapy*
Randomized Controlled Trials as Topic
Recurrence
Salvage Therapy
Stem Cell Transplantation / methods*
Transplantation, Autologous

Substances

Cytarabine
Etoposide
Cyclophosphamide
Carmustine

Supplementary concepts

BAEC protocol